𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selegiline in Alzheimer's disease: A review

✍ Scribed by Yang, Pei-Pei; Kuang, Wei-Wei; Xu, Yun; Li, Shao-Min; Han, Tao


Book ID
124115703
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
179 KB
Volume
15
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


SELEGILINE IN THE TREATMENT OF BEHAVIOUR
✍ BRIAN A. LAWLOR; PAUL S. AISEN; CYNTHIA GREEN; ELIZABETH FINE; JAMES SCHMEIDLER πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient

Biomarkers in Alzheimer's Disease: A Rev
✍ Chintamaneni, Meena; Bhaskar, Manju πŸ“‚ Article πŸ“… 2012 πŸ› Hindawi (International Scholarly Research Network) 🌐 English βš– 487 KB
Selegiline in Parkinson's disease
✍ H. TerΓ€vΓ€inen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 430 KB